Alnajashi, H. (2025). Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment. Journal of Contemporary Medical Sciences, 11(4). https://doi.org/10.22317/jcms.v11i4.1916